CMT Capital Markets Trading’s Novo Nordisk NVO Stock Holding History

CMT Capital Markets Trading’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$526K	Buy	+10,978	New	+$472K	﹤0.01%	333
2026 Q1	–	Sell	-62,226	Closed	-$2.95M	–	408
2025 Q4	$3.17M	Buy	62,226 +2,937	+5%	+$150K	0.03%	202
2025 Q3	$3.29M	Buy	59,289 +9,137	+18%	+$535K	0.03%	203
2025 Q2	$3.46M	Buy	50,152 +7,706	+18%	+$524K	0.04%	172
2025 Q1	$2.95M	Buy	+42,446	New	+$3.51M	0.04%	171

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CMT Capital Markets Trading's NVO Position: Q2 2026 in Review

CMT Capital Markets Trading opened a new position in Novo Nordisk (NVO) in Q2 2026: 10,978 shares worth $526K. The stake represents ﹤0.01% of the portfolio and ranks #333 among its holdings. This is a return to the name: CMT Capital Markets Trading previously reported a position in NVO as recently as Q4 2025.

CMT Capital Markets Trading first reported a position in NVO in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.46M in Q2 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

CMT Capital Markets Trading held 10,978 shares of Novo Nordisk worth $526K as of Q2 2026.
Novo Nordisk was a new CMT Capital Markets Trading position in Q2 2026.
Novo Nordisk made up ﹤0.01% of CMT Capital Markets Trading's portfolio in Q2 2026, its #333 holding.
CMT Capital Markets Trading first reported a position in Novo Nordisk in Q1 2025 and has held it in 5 quarters since.
CMT Capital Markets Trading's Novo Nordisk position peaked at $3.46M in Q2 2025.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on CMT Capital Markets Trading's 13F filing for Q2 2026, filed 13 Aug 2026.